Article Text

Download PDFPDF
CASE REPORT
Compound heterozygous mutations with novel missense ABCA12 mutation in harlequin ichthyosis
  1. Benny Kai Guo Loo1,
  2. Melissa Jeanne Batilando2,
  3. Ene Choo Tan3,
  4. Mark Jean Aan Koh4
  1. 1Department of Paediatric Medicine, KK Women’s and Children’s Hospital, Singapore, Singapore
  2. 2Department of Neonatology, KK Women’s and Children’s Hospital, Singapore, Singapore
  3. 3KK Research Centre, KK Women’s and Children’s Hospital, Singapore, Singapore
  4. 4Department of Dermatology, KK Women’s and Children’s Hospital, Singapore, Singapore
  1. Correspondence to Dr Benny Kai Guo Loo, benny.loo.k.g{at}singhealth.com.sg

Summary

Harlequin ichthyosis (HI) is the most severe form of autosomal recessive congenital ichthyosis, presenting at birth with distinctive facial features and thick, plate-like scales over the entire body. The abnormal skin barrier predisposes the patient to multiple complications, including dehydration and sepsis. Mortality rates of babies with HI have been greatly reduced since the introduction of systemic retinoid therapy. Mutations in ABCA12 have been found to lead to HI. Most of these mutations are truncation or deletion mutations in the conserved region of the protein, leading to severe loss of ABCA12 function. We report a case of HI caused by a compound heterozygous mutation (a known single nucleotide deletion and a novel single nucleotide substitution) in the ABCA12 gene.

  • dermatology
  • genetics
  • neonatal intensive care
  • congenital disorders

Statistics from Altmetric.com

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Footnotes

  • Contributors Concept and planning, acquisition of data and analysis, draft and revision, and final approval: BKGL, MJB, ECT, MJAK.

  • Competing interests None declared.

  • Patient consent Obtained.

  • Provenance and peer review Not commissioned; externally peer reviewed.